Richard A. Miller M.D., President and CEO at Corvus Pharmaceuticals, Inc. (CRVS), bought 1,155,268 shares at $1.73 ($2.0M) on 2024-05-06, disclosed to the SEC on 2024-05-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.73 | 577,634 | $999K | 50.0% |
| 2 | $1.73 | 577,634 | $999K | 50.0% |
| Total | $1.73 avg | 1,155,268 | $2.0M | 100% |
| Filing → |
| CRVS | BUY | 2022-09-28 | $19K | — | Filing → |
| CRVS | BUY | 2022-09-20 | $16K | — | Filing → |
| CRVS | BUY | 2022-06-28 | $10K | — | Filing → |